These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34893086)

  • 21. FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway.
    Chen E; Huang J; Chen M; Wu J; Ouyang P; Wang X; Shi D; Liu Z; Zhu W; Sun H; Yang S; Zhang B; Deng W; Qiu H; Xie F
    J Transl Med; 2023 Feb; 21(1):134. PubMed ID: 36814284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway.
    Li W; Ma H; Liu M
    Mol Biotechnol; 2021 Nov; 63(11):1081-1091. PubMed ID: 34236626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
    Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
    Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.
    Hwang CF; Shiu LY; Su LJ; Yu-Fang Yin ; Wang WS; Huang SC; Chiu TJ; Huang CC; Zhen YY; Tsai HT; Fang FM; Huang TL; Chen CH
    PLoS One; 2013; 8(12):e84218. PubMed ID: 24386352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation-associated silencing of miR-9-1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2.
    Xu QL; Luo Z; Zhang B; Qin GJ; Zhang RY; Kong XY; Tang HY; Jiang W
    Cancer Sci; 2021 Oct; 112(10):4127-4138. PubMed ID: 34382305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt/β-catenin-Lin28/let7-PDK1 cascade.
    Cai CF; Ye GD; Shen DY; Zhang W; Chen ML; Chen XX; Han DX; Mi YJ; Luo QC; Cai WY; Yang SY
    J Exp Clin Cancer Res; 2018 May; 37(1):104. PubMed ID: 29764469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of MTHFD2 inhibits proliferation and migration of nasopharyngeal carcinoma cells through the ERK signaling pathway.
    Wu S; Cai W; Shi Z; Ming X; Yang X; Zhou Y; Chen X; Yang M
    Biochem Biophys Res Commun; 2022 Jul; 614():47-55. PubMed ID: 35567943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling.
    Pan S; Liang S; Wang X
    Life Sci; 2021 Aug; 278():119581. PubMed ID: 33961854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway.
    Zhang J; Zhou J; Xiao S
    Anticancer Drugs; 2020 Oct; 31(9):932-941. PubMed ID: 32282369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRD7 expression and c-Myc activation forms a double-negative feedback loop that controls the cell proliferation and tumor growth of nasopharyngeal carcinoma by targeting oncogenic miR-141.
    Liu Y; Zhao R; Wei Y; Li M; Wang H; Niu W; Zhou Y; Qiu Y; Fan S; Zhan Y; Xiong W; Zhou Y; Li X; Li Z; Li G; Zhou M
    J Exp Clin Cancer Res; 2018 Mar; 37(1):64. PubMed ID: 29559001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
    Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN.
    Han JB; Huang ML; Li F; Yang R; Chen SM; Tao ZZ
    Cancer Biother Radiopharm; 2020 Oct; 35(8):615-625. PubMed ID: 32101017
    [No Abstract]   [Full Text] [Related]  

  • 34. Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.
    Ou H; Li Y; Kang M
    PLoS One; 2014; 9(11):e109929. PubMed ID: 25365510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
    Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
    Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway.
    Wang SC; Lin XL; Wang HY; Qin YJ; Chen L; Li J; Jia JS; Shen HF; Yang S; Xie RY; Wei F; Gao F; Rong XX; Yang J; Zhao WT; Zhang TT; Shi JW; Yao KT; Luo WR; Sun Y; Xiao D
    Oncotarget; 2015 Nov; 6(34):36713-30. PubMed ID: 26452025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
    Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
    Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling.
    Qu JQ; Yi HM; Ye X; Zhu JF; Yi H; Li LN; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Xiao ZQ
    Mol Cancer Ther; 2015 Nov; 14(11):2653-64. PubMed ID: 26304234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma.
    Hu Q; Lin X; Ding L; Zeng Y; Pang D; Ouyang N; Xiang Y; Yao H
    Cancer Med; 2018 Aug; 7(8):3862-3874. PubMed ID: 29936709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth.
    Li Y; Zhu Z; Zhang S; Yu D; Yu H; Liu L; Cao X; Wang L; Gao H; Zhu M
    PLoS One; 2011 Mar; 6(3):e17794. PubMed ID: 21423629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.